Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 23

1.

Designing Magnetically Responsive Biohybrids Composed of Cord Blood-Derived Natural Killer Cells and Iron Oxide Nanoparticles.

Burga RA, Khan DH, Agrawal N, Bollard CM, Fernandes R.

Bioconjug Chem. 2019 Feb 22. doi: 10.1021/acs.bioconjchem.9b00048. [Epub ahead of print]

PMID:
30779553
2.

First Report of New Delhi Metallo-β-Lactamase Carbapenemase-Producing Acinetobacter baumannii in Peru.

Rocha C, Bernal M, Canal E, Rios P, Meza R, Lopez M, Burga R, Abadie R, Pizango M, Diaz E, Briones A, Ramal-Asayag C, Vicente W, Regeimbal J, McCoy A.

Am J Trop Med Hyg. 2019 Jan 21. doi: 10.4269/ajtmh.18-0802. [Epub ahead of print]

PMID:
30675848
3.

Antibiotic Resistance of Campylobacter Species in a Pediatric Cohort Study.

Schiaffino F, Colston JM, Paredes-Olortegui M, François R, Pisanic N, Burga R, Peñataro-Yori P, Kosek MN.

Antimicrob Agents Chemother. 2019 Jan 29;63(2). pii: e01911-18. doi: 10.1128/AAC.01911-18. Print 2019 Feb.

4.

The other Campylobacters: Not innocent bystanders in endemic diarrhea and dysentery in children in low-income settings.

François R, Yori PP, Rouhani S, Siguas Salas M, Paredes Olortegui M, Rengifo Trigoso D, Pisanic N, Burga R, Meza R, Meza Sanchez G, Gregory MJ, Houpt ER, Platts-Mills JA, Kosek MN.

PLoS Negl Trop Dis. 2018 Feb 7;12(2):e0006200. doi: 10.1371/journal.pntd.0006200. eCollection 2018 Feb.

5.

Composite iron oxide-Prussian blue nanoparticles for magnetically guided T1-weighted magnetic resonance imaging and photothermal therapy of tumors.

Kale SS, Burga RA, Sweeney EE, Zun Z, Sze RW, Tuesca A, Subramony JA, Fernandes R.

Int J Nanomedicine. 2017 Sep 5;12:6413-6424. doi: 10.2147/IJN.S144515. eCollection 2017.

6.

Cord blood natural killer cells expressing a dominant negative TGF-β receptor: Implications for adoptive immunotherapy for glioblastoma.

Yvon ES, Burga R, Powell A, Cruz CR, Fernandes R, Barese C, Nguyen T, Abdel-Baki MS, Bollard CM.

Cytotherapy. 2017 Mar;19(3):408-418. doi: 10.1016/j.jcyt.2016.12.005. Epub 2017 Jan 19.

PMID:
28109751
7.

Photothermal therapy improves the efficacy of a MEK inhibitor in neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors.

Sweeney EE, Burga RA, Li C, Zhu Y, Fernandes R.

Sci Rep. 2016 Nov 11;6:37035. doi: 10.1038/srep37035.

8.

Prussian blue nanoparticle-based photothermal therapy combined with checkpoint inhibition for photothermal immunotherapy of neuroblastoma.

Cano-Mejia J, Burga RA, Sweeney EE, Fisher JP, Bollard CM, Sandler AD, Cruz CRY, Fernandes R.

Nanomedicine. 2017 Feb;13(2):771-781. doi: 10.1016/j.nano.2016.10.015. Epub 2016 Nov 5.

PMID:
27826115
9.

Improving efficacy of cancer immunotherapy by genetic modification of natural killer cells.

Burga RA, Nguyen T, Zulovich J, Madonna S, Ylisastigui L, Fernandes R, Yvon E.

Cytotherapy. 2016 Nov;18(11):1410-1421. doi: 10.1016/j.jcyt.2016.05.018. Epub 2016 Jul 12. Review.

PMID:
27421740
10.

Conjugating Prussian blue nanoparticles onto antigen-specific T cells as a combined nanoimmunotherapy.

Burga RA, Patel S, Bollard CM, Y Cruz CR, Fernandes R.

Nanomedicine (Lond). 2016 Jul;11(14):1759-67. doi: 10.2217/nnm-2016-0160. Epub 2016 Jul 7.

11.

Phase I Hepatic Immunotherapy for Metastases Study of Intra-Arterial Chimeric Antigen Receptor-Modified T-cell Therapy for CEA+ Liver Metastases.

Katz SC, Burga RA, McCormack E, Wang LJ, Mooring W, Point GR, Khare PD, Thorn M, Ma Q, Stainken BF, Assanah EO, Davies R, Espat NJ, Junghans RP.

Clin Cancer Res. 2015 Jul 15;21(14):3149-59. doi: 10.1158/1078-0432.CCR-14-1421. Epub 2015 Apr 7.

12.

Liver myeloid-derived suppressor cells expand in response to liver metastases in mice and inhibit the anti-tumor efficacy of anti-CEA CAR-T.

Burga RA, Thorn M, Point GR, Guha P, Nguyen CT, Licata LA, DeMatteo RP, Ayala A, Joseph Espat N, Junghans RP, Katz SC.

Cancer Immunol Immunother. 2015 Jul;64(7):817-29. doi: 10.1007/s00262-015-1692-6. Epub 2015 Apr 8.

13.

Santa Clara de Nanay: the MAL-ED cohort in Peru.

Yori PP, Lee G, Olórtegui MP, Chávez CB, Flores JT, Vasquez AO, Burga R, Pinedo SR, Asayag CR, Black RE, Caulfield LE, Kosek M.

Clin Infect Dis. 2014 Nov 1;59 Suppl 4:S310-6. doi: 10.1093/cid/ciu460.

PMID:
25305303
14.

Neutrophil:lymphocyte ratios and serum cytokine changes after hepatic artery chimeric antigen receptor-modified T-cell infusions for liver metastases.

Saied A, Licata L, Burga RA, Thorn M, McCormack E, Stainken BF, Assanah EO, Khare PD, Davies R, Espat NJ, Junghans RP, Katz SC.

Cancer Gene Ther. 2014 Nov;21(11):457-62. doi: 10.1038/cgt.2014.50. Epub 2014 Oct 3.

15.

Liver metastases induce reversible hepatic B cell dysfunction mediated by Gr-1+CD11b+ myeloid cells.

Thorn M, Point GR, Burga RA, Nguyen CT, Joseph Espat N, Katz SC.

J Leukoc Biol. 2014 Nov;96(5):883-94. doi: 10.1189/jlb.3A0114-012RR. Epub 2014 Aug 1.

16.

Biliary obstruction results in PD-1-dependent liver T cell dysfunction and acute inflammation mediated by Th17 cells and neutrophils.

Licata LA, Nguyen CT, Burga RA, Falanga V, Espat NJ, Ayala A, Thorn M, Junghans RP, Katz SC.

J Leukoc Biol. 2013 Oct;94(4):813-23. doi: 10.1189/jlb.0313137. Epub 2013 Jul 24.

17.

Anti-KIT designer T cells for the treatment of gastrointestinal stromal tumor.

Katz SC, Burga RA, Naheed S, Licata LA, Thorn M, Osgood D, Nguyen CT, Espat NJ, Fletcher JA, Junghans RP.

J Transl Med. 2013 Feb 21;11:46. doi: 10.1186/1479-5876-11-46.

18.

Symptomatic and asymptomatic Campylobacter infections associated with reduced growth in Peruvian children.

Lee G, Pan W, Peñataro Yori P, Paredes Olortegui M, Tilley D, Gregory M, Oberhelman R, Burga R, Chavez CB, Kosek M.

PLoS Negl Trop Dis. 2013;7(1):e2036. doi: 10.1371/journal.pntd.0002036. Epub 2013 Jan 31.

19.

Facilitated molecular typing of Shigella isolates using ERIC-PCR.

Kosek M, Yori PP, Gilman RH, Vela H, Olortegui MP, Chavez CB, Calderon M, Bao JP, Hall E, Maves R, Burga R, Sanchez GM.

Am J Trop Med Hyg. 2012 Jun;86(6):1018-25. doi: 10.4269/ajtmh.2012.11-0671.

20.

A functional agarose-hydroxyapatite scaffold for osteochondral interface regeneration.

Khanarian NT, Haney NM, Burga RA, Lu HH.

Biomaterials. 2012 Jul;33(21):5247-58. doi: 10.1016/j.biomaterials.2012.03.076. Epub 2012 Apr 22.

21.

Epidemiology of highly endemic multiply antibiotic-resistant shigellosis in children in the Peruvian Amazon.

Kosek M, Yori PP, Pan WK, Olortegui MP, Gilman RH, Perez J, Chavez CB, Sanchez GM, Burga R, Hall E.

Pediatrics. 2008 Sep;122(3):e541-9. doi: 10.1542/peds.2008-0458. Epub 2008 Aug 18. Erratum in: Pediatrics. 2008 Nov;122(5):1163-4..

22.

Short report: High incidence of shigellosis among Peruvian soldiers deployed in the Amazon River basin.

Jones FR, Sanchez JL, Meza R, Batsel TM, Burga R, Canal E, Block K, Perez J, Bautista CT, Escobedo J, Walz SE.

Am J Trop Med Hyg. 2004 Jun;70(6):663-5.

PMID:
15211010
23.

[Treatment of intestinal trichomoniasis with the new antibiotic aminosidine sulphate].

Lumbreras H, Cantella R, Burga R.

Rev Bras Gastroenterol. 1967 Nov-Dec;19(6):45-7. Portuguese. No abstract available.

PMID:
5595393

Supplemental Content

Support Center